Pulmonary toxicity of drugs used to treat systemic autoimmune diseases

被引：14
作者：
Libby, D
White, DA
机构：
[1] New York Presbyterian Hosp, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[3] Cornell Univ, Coll Med, Dept Med, New York, NY USA
来源：
CLINICS IN CHEST MEDICINE | 1998年 / 19卷 / 04期
关键词：
D O I：
10.1016/S0272-5231(05)70118-0
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
A number of drugs used to treat systemic autoimmune diseases can cause respiratory complications. These include bronchospasm, noncardiac pulmonary edema, interstitial pneumonitis and fibrosis, hypersensitivity, and numerous other disorders. Additionally, some of these drugs increase the risk of infections, particularly with opportunistic organisms. This article reviews the clinical presentation and mechanism of toxicity of drug related pulmonary complications.
引用
收藏
页码：809 / +
页数：14
相关论文
共 95 条
[91]   BENEFICIAL EFFECT OF INTRAVENOUS CYCLOPHOSPHAMIDE AND ORAL PREDNISONE ON D-PENICILLAMINE ASSOCIATED BRONCHIOLITIS OBLITERANS [J].
VANDELAAR, MAFJ ;
WESTERMANN, CJJ ;
WAGENAAR, SS ;
DINANT, HJ .
ARTHRITIS AND RHEUMATISM, 1985, 28 (01) :93-97
[92]   PHARMACOLOGY - TOWARDS A BETTER ASPIRIN [J].
VANE, J .
NATURE, 1994, 367 (6460) :215-216
[93]   AN INVESTIGATION OF THE ACTION OF DISEASE MODIFYING ANTIRHEUMATIC DRUGS ON THE RHEUMATOID SYNOVIAL-MEMBRANE - REDUCTION IN LYMPHOCYTE-T SUBPOPULATIONS AND HLA-DP AND DQ ANTIGEN EXPRESSION AFTER GOLD OR PENICILLAMINE THERAPY [J].
WALTERS, MT ;
SMITH, JL ;
MOORE, K ;
EVANS, PR ;
CAWLEY, MID .
ANNALS OF THE RHEUMATIC DISEASES, 1987, 46 (01) :7-16
[94]   PULMONARY-INFILTRATES AND EOSINOPHILIA ASSOCIATED WITH SULFASALAZINE [J].
WANG, KK ;
BOWYER, BA ;
FLEMING, CR ;
SCHROEDER, KW .
MAYO CLINIC PROCEEDINGS, 1984, 59 (05) :343-346
[95]  
WEINSTEIN A, 1980, PROGR CLIN IMMUNOLOG, V40, P1
12345678910